Search results
Found 30016 matches for
People with Rheumatoid Arthritis (RA) could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient reported pain scores. Otilimab is a monoclonal antibody, biologic drug, which targets and suppresses the inflammatory cytokine GM-CSF.
Botnar Institute Student Symposium 2025
Wednesday, 11 June 2025
BISS is back! Join us for a day of presentations, posters, activities and quizzes to celebrate our brilliant Botnar students.
Trials Expertise Session: The role of a Trial Manager in a Trial Management Group (TMG) *online*
Thursday, 12 June 2025, 10am to 11am
Trials Expertise Session: Communication skills in Clinical Trials for Trial Managers *online*
Wednesday, 26 March 2025, 10am to 11am
Trials Expertise Session: Site Feasibility Questionnaires (SFQ) & Site selection *Hybrid*
Wednesday, 21 May 2025, 2pm to 3pm
Meet Chris
-
Christopher Buckley
Kennedy Professor of Translational Rheumatology and Director of Clinical Research
